Compare PKST & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKST | ZVRA |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.7M | 472.9M |
| IPO Year | 2014 | 2015 |
| Metric | PKST | ZVRA |
|---|---|---|
| Price | $20.81 | $9.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $21.00 | ★ $21.71 |
| AVG Volume (30 Days) | 540.8K | ★ 887.8K |
| Earning Date | 05-22-2026 | 06-12-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | N/A | ★ 1.35 |
| Revenue | $105,981,000.00 | ★ $106,470,000.00 |
| Revenue This Year | $17.34 | $333.64 |
| Revenue Next Year | $13.81 | $44.19 |
| P/E Ratio | ★ N/A | $7.54 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $10.70 | $6.19 |
| 52 Week High | $20.97 | $13.16 |
| Indicator | PKST | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 81.48 | 60.02 |
| Support Level | $20.68 | $8.32 |
| Resistance Level | $20.95 | $10.05 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.22 | 0.14 |
| Stochastic Oscillator | 47.62 | 55.05 |
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.